To verify whether TET1 or TRPV4 regulates bone cancer pain, we respectively injected the TET1 inhibitor Bobcat339 and TRPV4 inhibitor HC067047 intrathecally into BCP rats. The gene discussed is TRPV4; the disease is bone cancer.